Raymond J. Henley Iii

Array ( [id] => 720305 [patent_doc_number] => 07049328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Use for deferiprone' [patent_app_type] => utility [patent_app_number] => 10/311814 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 13509 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049328.pdf [firstpage_image] =>[orig_patent_app_number] => 10311814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7412185 [patent_doc_number] => 20040106669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Remedies for cirrhosis' [patent_app_type] => new [patent_app_number] => 10/312366 [patent_app_country] => US [patent_app_date] => 2002-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7087 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106669.pdf [firstpage_image] =>[orig_patent_app_number] => 10312366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405234 [patent_doc_number] => 20040024053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Vitamin c compositions' [patent_app_type] => new [patent_app_number] => 10/362867 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 736 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20040024053.pdf [firstpage_image] =>[orig_patent_app_number] => 10362867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1558657 [patent_doc_number] => 06436448 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Method for the treatment of lymphedema using guaifenesin' [patent_app_type] => B1 [patent_app_number] => 09/891136 [patent_app_country] => US [patent_app_date] => 2001-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4737 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436448.pdf [firstpage_image] =>[orig_patent_app_number] => 09891136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533228 [patent_doc_number] => 06410565 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => '1-adrenergic receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 09/869406 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2531 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410565.pdf [firstpage_image] =>[orig_patent_app_number] => 09869406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361727 [patent_doc_number] => 20020058674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Systems and methods for treating a mucosal surface' [patent_app_type] => new [patent_app_number] => 09/886012 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15468 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058674.pdf [firstpage_image] =>[orig_patent_app_number] => 09886012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7079205 [patent_doc_number] => 20010041734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'Method of treating traumatic brain injury and other neuronal disorders' [patent_app_type] => new [patent_app_number] => 09/886206 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1405 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041734.pdf [firstpage_image] =>[orig_patent_app_number] => 09886206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433405 [patent_doc_number] => 06340695 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Rapid onset formulation' [patent_app_type] => B1 [patent_app_number] => 09/885051 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3492 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340695.pdf [firstpage_image] =>[orig_patent_app_number] => 09885051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496801 [patent_doc_number] => 20020025347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Treatment of diabetic nephropathy and microalbuminuria' [patent_app_type] => new [patent_app_number] => 09/885523 [patent_app_country] => US [patent_app_date] => 2001-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10678 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025347.pdf [firstpage_image] =>[orig_patent_app_number] => 09885523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240008 [patent_doc_number] => 06686340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells' [patent_app_type] => B2 [patent_app_number] => 09/885347 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 1847 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686340.pdf [firstpage_image] =>[orig_patent_app_number] => 09885347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460215 [patent_doc_number] => 06391921 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Treatment of inflammation with 2,4,6-trihydroxy--para-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives' [patent_app_type] => B1 [patent_app_number] => 09/884245 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 7872 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391921.pdf [firstpage_image] =>[orig_patent_app_number] => 09884245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291916 [patent_doc_number] => 20020055535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Method for treating pain in humans' [patent_app_type] => new [patent_app_number] => 09/883474 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8048 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055535.pdf [firstpage_image] =>[orig_patent_app_number] => 09883474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6225472 [patent_doc_number] => 20020004518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Method of treating disorders related to protease-activated receptors-induced cell activation' [patent_app_type] => new [patent_app_number] => 09/883742 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7502 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004518.pdf [firstpage_image] =>[orig_patent_app_number] => 09883742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889286 [patent_doc_number] => 20020013335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Method of treating cardiovascular disease' [patent_app_type] => new [patent_app_number] => 09/880295 [patent_app_country] => US [patent_app_date] => 2001-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3703 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013335.pdf [firstpage_image] =>[orig_patent_app_number] => 09880295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243221 [patent_doc_number] => 20020045636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Method of treating the syndrome of coronary heart disease risk factors in humans' [patent_app_type] => new [patent_app_number] => 09/878834 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6010 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045636.pdf [firstpage_image] =>[orig_patent_app_number] => 09878834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392632 [patent_doc_number] => 06544983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-08 [patent_title] => 'Diazepinoindoles for the treatment of chronic obstructive pulmonary disease' [patent_app_type] => B2 [patent_app_number] => 09/876719 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4490 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544983.pdf [firstpage_image] =>[orig_patent_app_number] => 09876719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4329306 [patent_doc_number] => 06319942 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Topical scar treatments using alkanolamines' [patent_app_type] => 1 [patent_app_number] => 9/875317 [patent_app_country] => US [patent_app_date] => 2001-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4283 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319942.pdf [firstpage_image] =>[orig_patent_app_number] => 875317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033653 [patent_doc_number] => 20020019417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Methods, compounds and compositions for treating gout' [patent_app_type] => new [patent_app_number] => 09/870782 [patent_app_country] => US [patent_app_date] => 2001-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7383 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019417.pdf [firstpage_image] =>[orig_patent_app_number] => 09870782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1457658 [patent_doc_number] => 06391284 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Nonalcoholic pharmaceutical preparations from formulations including alcohol and process for the preparation thereof' [patent_app_type] => B1 [patent_app_number] => 09/871466 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3227 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391284.pdf [firstpage_image] =>[orig_patent_app_number] => 09871466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6413354 [patent_doc_number] => 20020183301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy' [patent_app_type] => new [patent_app_number] => 09/871441 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8503 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183301.pdf [firstpage_image] =>[orig_patent_app_number] => 09871441 [rel_patent_id] =>[rel_patent_doc_number] =>)